ResearcherSun Yat-sen UniversityActive in the last 2 years

Zhiguo Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8546-9750; OpenAlex author ID A5100437416. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 14

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer. Co-author DOI 10.1016/j.mtbio.2025.101696 ↗
Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. Co-author DOI 10.21037/gs-21-28 ↗
Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. Co-author DOI 10.1186/s12943-020-01196-4 ↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wei Li · 1 shared paper, 2025 · strength 0.27
- Paper A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer. DOI 10.1016/j.mtbio.2025.101696 ↗
Jiawei Wang · 1 shared paper, 2025 · strength 0.27
- Paper A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer. DOI 10.1016/j.mtbio.2025.101696 ↗
Zhiqiang Fu · 2 shared papers, 2020–2021 · strength 0.24
- Paper Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. DOI 10.21037/gs-21-28 ↗
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Quanbo Zhou · 2 shared papers, 2020–2021 · strength 0.24
- Paper Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. DOI 10.21037/gs-21-28 ↗
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Bin Juan Yang · 1 shared paper, 2021 · strength 0.13
- Paper Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. DOI 10.21037/gs-21-28 ↗
Yanan Lu · 1 shared paper, 2021 · strength 0.13
- Paper Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. DOI 10.21037/gs-21-28 ↗
Dan Su · 1 shared paper, 2021 · strength 0.13
- Paper Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. DOI 10.21037/gs-21-28 ↗
Leyi Huang · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Rufu Chen · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Xiaofeng Guo · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Changhao Chen · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Zhihua Li · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Yao Kong · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗
Yuming Luo · 1 shared paper, 2020 · strength 0.10
- Paper Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. DOI 10.1186/s12943-020-01196-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.